Atai Beckley N.V (ATAI) NASDAQ
4.77
+0.06(+1.27%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
4.77
+0.06(+1.27%)
Currency In USD
Address
Prof. J.H. Bavincklaan 7
Amstelveen, 1183 AT
Netherlands (Kingdom of the)
Phone
31 20 793 2536
Website
Sector
Healthcare
Industry
Medical - Pharmaceuticals
Employees
54
First IPO Date
June 18, 2021
| Name | Title | Pay | Year Born |
| Srinivas G. Rao | Co-Founder, Chief Executive Officer & Executive Director | 834,460 | 1969 |
| Christian Angermayer | Co-Founder & Chairman of the Board | 73,104 | 1978 |
| Anne Johnson | Chief Financial Officer | 574,815 | 1969 |
| Kevin Craig | Chief Medical Officer | 615,378 | 1973 |
| Ashleigh Barreto | Senior Director of Investor Relations | 0 | N/A |
| Gerd G. Kochendoerfer | Chief Operating Officer | 0 | 1968 |
| Glenn Short | Chief Scientific Officer | 0 | 1970 |
| Robert Conley | Chief Research & Development Officer | 0 | N/A |
| Ryan Barrett | Chief Legal & Business Officer | 0 | 1981 |
Atai Beckley NV is a clinical-stage biopharmaceutical company. It engages in the treatment of mental health disorders. The company was founded by Christian Angermayer, Florian Brand, Srinivas Rao and Lars Christian Wilde in June 2018 and is headquartered in Amstelveen, Netherlands.